Page last updated: 2024-09-05

bifeprunox and piperidines

bifeprunox has been researched along with piperidines in 2 studies

Compound Research Comparison

Studies
(bifeprunox)
Trials
(bifeprunox)
Recent Studies (post-2010)
(bifeprunox)
Studies
(piperidines)
Trials
(piperidines)
Recent Studies (post-2010) (piperidines)
3011240,2355,22114,545

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corsini, GU; Maggio, R; Millan, MJ; Novi, F1
Arnt, J; Bétry, C; Etievant, A; Haddjeri, N1

Other Studies

2 other study(ies) available for bifeprunox and piperidines

ArticleYear
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.
    Journal of neurochemistry, 2007, Volume: 102, Issue:4

    Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzoxazoles; Carrier Proteins; Chlorocebus aethiops; Clozapine; COS Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Piperazines; Piperidines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Transfection

2007
Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
    Neuroscience letters, 2009, Aug-21, Volume: 460, Issue:1

    Topics: Action Potentials; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Indoles; Male; Neurons; Piperazines; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulfones; Tetrahydronaphthalenes; Ventral Tegmental Area

2009